{
  "pdf_name": "FlublokPI",
  "pipeline_started_at": "2025-07-28T09:47:57.369874",
  "pipeline_completed_at": "2025-07-28T09:48:42.797161",
  "pipeline_status": "completed",
  "agents": {
    "claim_verifier": {
      "status": "completed",
      "started_at": "2025-07-28T09:47:57.370079",
      "completed_at": "2025-07-28T09:48:42.797056"
    }
  },
  "config": {
    "continue_on_error": false,
    "agents": {
      "claim_verifier": {
        "model": "gpt-4.1",
        "standalone_claims": [
          "Flublok is approved for use in persons 18 years of age and older.",
          "Flublok is approved for use in children under 12 years old.",
          "The most common side effect of Flublok is injection site pain.",
          "Flublok contains egg proteins.",
          "Guillain-Barr\u00e9 syndrome history requires careful consideration before giving Flublok.",
          "Flublok is a recombinant influenza vaccine."
        ]
      }
    },
    "claims": [
      "Flublok is approved for use in persons 18 years of age and older.",
      "Flublok is approved for use in children under 12 years old.",
      "The most common side effect of Flublok is injection site pain.",
      "Flublok contains egg proteins.",
      "Guillain-Barr\u00e9 syndrome history requires careful consideration before giving Flublok.",
      "Flublok is a recombinant influenza vaccine."
    ]
  }
}